Year All20252024202320222021202020192018201720162015201420122011 Oct 8, 2018 Ardelyx Showcases New Data from T3MPO-3 Long-Term Safety Trial of Tenapanor for IBS-C in Presidential Poster at ACG 2018 Annual Meeting Oct 4, 2018 Ardelyx to Host Its First Annual Investor Day Focused on Treatment Landscape of Renal Disorders Sep 13, 2018 Ardelyx Submits New Drug Application for U.S. Marketing Authorization of Tenapanor for IBS-C to U.S. Food and Drug Administration Aug 29, 2018 Ardelyx Announces Science Translational Medicine Publication Detailing Tenapanor's Unique Mechanism of Action Inhibiting Paracellular Phosphate Absorption Aug 7, 2018 Ardelyx Reports Second Quarter 2018 Financial Results and Recent Highlights Aug 1, 2018 Ardelyx Announces Date of Second Quarter 2018 Financial Results and Conference Call May 29, 2018 Ardelyx to Present at the Jefferies 2018 Global Healthcare Conference May 22, 2018 Ardelyx Announces Pricing of Public Offering of Common Stock May 21, 2018 Ardelyx Raises $50 Million in Loan Agreement with Solar Capital and Bridge Bank May 21, 2018 Ardelyx Announces Proposed Public Offering of Common Stock